Acupuncture Combined with Chinese Herbal Medicine for Tubal Obstructive Infertility: A Systematic Review and Meta-Analysis

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-16

Acupuncture combined with Chinese herbal medicine improved pregnancy rates and tubal recanalization success while lowering ectopic pregnancy rates compared to hydrotubation for tubal obstructive infertility.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text

This systematic review and meta-analysis of randomized controlled trials evaluated acupuncture combined with Chinese herbal medicine versus fallopian tube hydrotubation for tubal obstructive infertility, searching eight databases from inception to July 31, 2022. Eighteen single-center trials (n=1623 total) reported outcomes including pregnancy rate, ectopic pregnancy rate, tubal recanalization success, and relief of clinical signs and symptoms; the pooled results found higher pregnancy rates (RR 1.74) and improved tubal recanalization (RR 1.37), with lower ectopic pregnancy odds (OR 0.61) and better symptom relief (OR 3.44). A major limitation acknowledged by the authors is methodological quality issues across included trials, including unclear allocation concealment and potential high risk of bias from lack of blinding in several studies. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Tubal obstruction is the leading cause of infertility. Acupuncture and Chinese herbal medicine (CHM) are widely used in treating tubal obstruction infertility (TOI), and clinical research is increasing. However, there is still controversy about its efficacy and safety. This systematic review aimed to assess the efficacy and safety of acupuncture and CHM in treating TOI. Methods: : We searched eight databases to collect randomized controlled trials comparing Hydrotubation with Acupuncture combined with CHM from inception to July 31, 2022. A total of 1580 papers were collected, and the methodological quality of the included trials was assessed in line with the criteria of the Cochrane risk of the bias assessment tool. In the end, only 18 randomized clinical trials met the requirements and were included. Results: : Meta-analysis showed that acupuncture and CHM was associated with a higher pregnancy rate [RR 1.74, 95% CI (1.54, 1.95), P < 0.00001] and a lower ectopic pregnancy rate [OR 0.61, 95 % CI (0.19, 1.92), P<0.0001]. The success rate of tubal recanalization was significantly improved with acupuncture combined with CHM treatment[RR 1.37, 95 % CI (1.20, 1.57), P<0.0001], and signs and symptoms were better relieved [OR 3.44, 95 % CI (2.22, 5.33), P<0.00001]. Conclusions: : This meta-analysis suggests that acupuncture and CHM can be used as complementary therapies to treat tubal obstructive infertility with better outcomes than Hydrotubation.
Full text 81,789 characters · extracted from preprint-html · click to expand
Acupuncture Combined with Chinese Herbal Medicine for Tubal Obstructive Infertility: A Systematic Review and Meta-Analysis | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Acupuncture Combined with Chinese Herbal Medicine for Tubal Obstructive Infertility: A Systematic Review and Meta-Analysis Wenrui Huang, Xia Han, Yixin Li, Tingting Huang, Huimin Jie This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-2059117/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background: Tubal obstruction is the leading cause of infertility. Acupuncture and Chinese herbal medicine (CHM) are widely used in treating tubal obstruction infertility (TOI), and clinical research is increasing. However, there is still controversy about its efficacy and safety. This systematic review aimed to assess the efficacy and safety of acupuncture and CHM in treating TOI. Methods: We searched eight databases to collect randomized controlled trials comparing Hydrotubation with Acupuncture combined with CHM from inception to July 31, 2022. A total of 1580 papers were collected, and the methodological quality of the included trials was assessed in line with the criteria of the Cochrane risk of the bias assessment tool. In the end, only 18 randomized clinical trials met the requirements and were included. Results: Meta-analysis showed that acupuncture and CHM was associated with a higher pregnancy rate [RR 1.74, 95% CI (1.54, 1.95), P < 0.00001] and a lower ectopic pregnancy rate [OR 0.61, 95 % CI (0.19, 1.92), P<0.0001]. The success rate of tubal recanalization was significantly improved with acupuncture combined with CHM treatment[RR 1.37, 95 % CI (1.20, 1.57), P<0.0001], and signs and symptoms were better relieved [OR 3.44, 95 % CI (2.22, 5.33), P<0.00001]. Conclusions: This meta-analysis suggests that acupuncture and CHM can be used as complementary therapies to treat tubal obstructive infertility with better outcomes than Hydrotubation. Acupuncture Chinese herbal medicines Tubal infertility Meta-analysis systematic review Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Introduction Common causes of female infertility include ovulatory dysfunction (e.g., PCOS), damaged or blocked fallopian tubes, endometriosis, and uterine fibroids [ 1 ] , among which tubal patency is abnormal due to tubal blockage, adhesions, etc. The resulting infertility is called Tubal Obstructive Infertility(TOI) [ 2 ] , accounting for 11–67% of female infertility. [ 3 ][ 4 ] As the primary infertility factor, tubal infertility seriously affects women's reproductive health and quality of life. Western medicine mainly adopts surgical methods to treat TOI, such as hysteroscopy, laparoscopy, and other minimally invasive techniques to mechanically dredge the fallopian tubes, to achieve the effect of loosening adhesions. Although the minimally invasive technique has an apparent curative effect, minor trauma, and short treatment time, once the fresh wound of the fallopian tube mucosa is infected, it will easily lead to re-adhesion, obstruction, and the possibility of inflammatory lesions. Although Assisted Reproductive Technologies(ART) have primarily solved the problem of tubal infertility, the pregnancy rate has not improved clinically, from about 29–35% [ 5 ] . There are also adverse reactions such as miscarriage, ectopic pregnancy, and ovarian hyperstimulation, which are unsuitable for promotion. Given the above phenomenon, there have been a large number of clinical research reports that Traditional Chinese Medicine has significant curative effects in the treatment of tubal obstructive infertility, such as eliminating chronic inflammation, reducing edema, restoring tubal function, and improving pregnancy rate, and has the advantages of less trauma, low cost, and high patient compliance [ 6 ] . Although there are many reports on controlled clinical trials of acupuncture combined with Chinese herbal medicine (CHM) in the treatment of tubal obstructive infertility, there is no systematic review of these trials in China and abroad, and it is difficult to determine an appropriate evidence-based treatment plan. Therefore, we conducted this study to evaluate the potential therapeutic effect of acupuncture combined with CHM in treating tubal obstructive infertility. Methods This study was conducted by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement. [ 7 ] Databases including the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI), VIP information database, Wanfang Data Information Site, and Chinese Biomedical Database (CBM) were searched from inception to July 31, 2022. We also manually searched conference proceedings, reference lists of relevant articles, and reviewed articles to obtain additional relevant data. The following search terms were used for searching databases: ("infertility, female" or "female infertility" or "subfertility") and ("fallopian tube diseases" or "tubal obstruction" or "fallopian tubal obstruction") and ("Chinese herbal drugs" or "Chinese herbal medicines" or "oriental herbal medicine" or "medicine, East Asian traditional" or "traditional Chinese medicine" or "medicine, Kampo") and ("acupuncture" or "moxibustion" or "point, acupuncture" or "acupoints" or "electroacupuncture" or "warming needle" or "auricular acupressure" or "auricular points") and ("randomized controlled trial" or "randomized" or "Placebo" or "RCT" ). Study selection and data extraction In this review, only RCTs were eligible for inclusion, comparing the efficacy and safety of acupuncture and CHM versus fallopian tube hydrotubation for TOI. A woman diagnosed with TOI was eligible for this research. (1) At least one year of regular sexual intercourse without contraception and male infertility;(2) The woman has not become pregnant, or a woman fails to conceive one year or more after a previous pregnancy; (3) infertility caused by oviduct obstruction can be identified with congested Oviduct under hysterosalpingogram (HSG), hysteroscopy, laparoscopy, or liquid flow under ultrasound hysterosalpingography. This study compares acupuncture combined with CHM and hydrotubation. In this review, Chinese medicine includes herbal decoctions, powder, and capsules. Acupuncture included body acupuncture and a warming needle. Interventions of the specific herbs and acupoints in the prescriptions should be provided. The control group interventions were Hydrotubation, which includes conventional hydrotubation, hysteroscopic hydrotubation, laparoscopic tubal correction with hydrotubation, and intervention therapy with hydrotubation and antibiotic drugs, with or without TCM treatment. The Primary outcome was the pregnancy rate. It is a positive urine or blood pregnancy test. Intrauterine pregnancy should be identified with intrauterine gestational sac Or fetal heartbeat by ultrasound. The Secondary outcome was tubal recanalization, and we defined the effectiveness of treatment as successful tubal recanalization or improvements detected by hysterosalpingography, hysteroscope, laparoscope, or ultrasound. The tertiary outcome was Relief of clinical symptoms and signs. The integration method was applied to determine the total effects in alleviating the signs and symptoms. We conducted the selection process through EndNote X7 software, a tool that allows multiple people to log in simultaneously. Thus, two review authors (HTT, XHM) independently screened studies by title and abstract to evaluate whether a study met the inclusion and exclusion criteria. We resolved disagreements by involving a third review author (LYX). We drew a PRISMA flow diagram to show the search results and the numbers of included and excluded trials. For all included trials, two review authors (HTT, XHM) independently extracted data using a data abstraction form and summarized trial characteristics in tables. From each included study, two review authors (HTT, XHM) derived baseline characteristics of TOI females, types of interventions (acupoints, drugs, doses), and outcomes. We intended to contact the study investigators for further data on methods and results if required. The criteria of Cochrane’s risk of bias assessment tool [ 8 ] evaluated the bias risks of included articles. Two evaluators were designated to assess the reports in terms of the following items by giving the results of “high," “low," and “unclear" independently: (1) Generation of random sequence; (2) Allocation concealment; (3) Blind method implementation to the researchers and subjects; (4) Blind method implementation to the outcome index evaluation; (5) Data integrity; (6) Selective report of study results; (7) Other bias sources. Data analysis and synthesis Analyses were performed using Revman 5 statistical software provided by Cochrane collaboration. We used the relative risk (RR) for enumeration data. If the incidences were low, we used the odds ratio (OR) and estimated the corresponding 95% confidence interval (CI). The Chi-square test was used to measure heterogeneity. We used the fixed effects meta-analysis modeling if between-study heterogeneity was not observed. In the presence of between-study heterogeneity, we analyzed the quality of the methodology, the age of patients, the time of follow-up visits, and the sample size of the trial to find the factors affecting heterogeneity, excluded trials of statistically significant differences, and did sensitivity analyses. If no factors were identified, we used the random effects meta-analysis modeling. Results In this review, 1580 relevant articles were retrieved. After importing all the studies into EndNote X7 software, 863 duplicate studies were excluded. By screening, titles, and abstracts of the remaining 33 records, 830 articles were excluded because of ineligibility, such as case reports, case series, traditional reviews, commentary articles, animal experiments, or not rigorously designed RCTs. Fifteen of the remaining 33 studies were excluded by examining the body texts. Among them, two articles had no relevant outcome; 13 studies didn't meet the inclusion of Intervention. Finally, 18 studies were selected for meta-analysis. (Fig. 1) Study characteristics This review included 18 RCTs. [ 9 – 26 ] All of them were single-center studies, including women, 837 in trial groups and 786 in control groups. All the available data compared acupuncture and CHM versus hydrotubation for TOI(table-1). All the incorporated documents were randomly allocated, and all the trials were considered a low risk of selection bias. All the included trials did not mention allocation concealment and were rated as unclear risk of bias. Ten studies provided information on blind methods and were assessed as having a “high” risk of bias. [ 9 – 11 , 13 – 16 , 22 – 23 , 25 – 26 ] . During treatment and follow-up, 18 trials did not report exclusion or loss and were rated low risk. The protocols of included studies have not been published, and all experiments have not been registered, which we judged as an unclear risk of bias. We found no potential within-study bias in the 18 documents and rated them low risk (Fig. 2 and Fig. 3). Clinical outcomes Eighteen trials [ 9 – 26 ] reported pregnancy rates which were categorical data. Between-study heterogeneity was tested (X² = 10.80, P = 0.87). No factors that cause heterogeneity were found through analysis. We then used fixed effects modeling for meta-analysis. The results indicated that compared with hydrotubation (with or without TCM treatment), Acupuncture combined with CHM was associated with higher pregnancy rates [RR 1.74, 95% CI (1.54, 1.95), P༜0.00001] (Fig. 4). The asymmetry funnel plot(Fig. 5) showed publication bias. Sixteen trials [ 9 – 10 , 12 – 14 , 16 – 26 ] reported the conditions of tubal recanalization. Heterogeneity was observed (x² = 21.76, P = 0.11). No factors that cause heterogeneity were found through analysis. We then used fixed effects modeling for meta-analysis. The results indicated that Acupuncture combined with CHM is more effective than hydrotubation. [RR 1.37, 95% CI (1.20, 1.57), P༜0.00001] (Fig. 4). Six trials [ 17 , 19 , 20 , 22 , 25 – 26 ] reported the relief of signs and symptoms, which were categorical data. No significant heterogeneity was observed (x² = 5.54, P = 0.35), we then used fixed effects modeling for meta-analysis. The results suggested that Acupuncture combined with CHM can better relieve the signs and symptoms than hydrotubation. [OR 3.44, 95% CI (2.22, 5.33), P༜0.00001] (Fig. 4). Among the 18 trials mentioned above, three reported cases of ectopic pregnancy [ 11 , 21 , 23 ] , which were categorical data. No significant heterogeneity was observed (x² = 0.04, P = 0.98); we therefore used fixed effects modeling for meta-analysis. The results showed that hydrotubation was associated with a higher incidence of ectopic pregnancy compared with Acupuncture combined with CHM [OR 0.61, 95% CI (0.19, 1.92), P = 0.40] (Fig. 4). Discussion In this study, we searched all the data about acupuncture combined with Chinese medicine for infertility caused by tubal obstructive and retrieved 33 relevant studies. Eighteen randomized controlled trials were included, involving 1623 patients. The results indicated that:(1) Compared with hydrotubation, acupuncture combined with CHM for tubal obstructive infertility was associated with a higher pregnancy rate, better tubal recanalization, and better relief of signs and symptoms. (2) The incidence of ectopic pregnancy was lower using acupuncture combined with CHM than with hydrotubation for infertility caused by tubal obstruction. This study suggests that there is a prospect for acupuncture combined with CHM in the treatment of infertility caused by tubal obstruction. Slight abdominal pain was observed during and after the operation, and recovery from the pain was achieved in a week without special treatment. No noticeable side effects were detected after drinking decoction, applying Chinese medicine externally, or by enema. Slight allergies in local areas were alleviated without any treatment. No abnormal changes were seen on lab test indexes (blood and urine routine examination) or type-B ultrasonic probe with pelvic cavity before and after the administration. Mechanisms of acupuncture and CHM Although the Acupuncture points and CHM selected in these 18 articles are not the same, we can still find more commonly used herbs and acupoints in them. The following twelve acupoints have been used in more than five (including five) studies, including Zigong(EX-CA1), Zhongji(RN3), Qihai(RN6), Sanyinjiao(SP6), Guanyuan(RN4), Shenshu(BL23), Zusanli(ST36), Xuehai(SP10), Taichong(LR3), Ganshu(BL18), Ciliao(BL32), Mingmen(DU4). The following eight herbs had been most frequently used in more than five (including five) studies, including Danggui(Angelica Sinensis), Chishao(Radix Paeoniae Rubra), Baizhu(Atractylodes macrocephala), Dangshen(Codonopsis pilosula), Gancao(liquorice), Danshen(Salvia miltiorrhiza), Lulutong(Fructus liquidambaris), Baijiangcao(Herbal patriniae). The evidence of Acupuncture and CHM for TOI includes the following aspects: (1)Improving the hemodynamics of the ovary and uterus. A study showed that Chinese herbal medicine treating salpingitis obstructive infertility could effectively improve the hemodynamic rheological indicators of the uterus and ovary. In this study, the hemorheological indexes of the rats in the tubal obstructive infertility model in the experimental group were significantly lower than those in the western medicine group treated with cefuroxime and metronidazole. Another study showed that acupuncture combined with traditional Chinese medicine in treating salpingitis obstructive infertility could inhibit the expression of sICAM-1 protein, effectively improve hemorheological indicators, and promote the absorption and dissipation of inflammation. [ 27 ][ 28 ] (2)Regulating immunity. A study confirmed that acupuncture could effectively increase the levels of β-endorphins in rats' peripheral blood and hypothalamus [ 29 ] . In regulating the female gonadal axis, β-endorphin, an endogenous opioid peptide, is a universal messenger of the nervous, endocrine, and immune systems and plays a crucial role in neuromodulation and maintaining the stability of the body's internal environment [ 30 ] . Domestic studies have also shown that acupuncture can regulate the endocrine system, stimulate ovarian function, and acupuncture can promote the absorption of inflammation. It has incomparable advantages for dredging the fallopian tubes, promoting the combination of sperm and egg, and improving the pregnancy rate [ 31 ] . (3)Regulates the hypothalamic-pituitary-ovarian axis. It has been reported at home and abroad that traditional Chinese medicine treatment can effectively improve women's ovarian function and increase the natural conception rate [ 32 ] [ 33 ] . A meta-analysis showed that treatment with CHM significantly reduced FSH levels in women [ 34 ] , and another study showed that Danggui Buxue decoction had estradiol activity in vitro [ 35 ] . The limitations of the included studies in this meta-analysis are as follows: Firstly, the methodological quality was low due to the lack of description of blinding in most of the included studies. Blinding is necessary to prevent study results from being influenced by placebo effects or observer bias [ 36 ] . However, in the related research on acupuncture, it is difficult to apply the blind method to the patient because acupuncture needs to be implemented on the patient. In addition, traditional Chinese medicine formulations are mainly decoctions, which can be better differentiated from clinical drug capsules or placebos. In conclusion, it is challenging to achieve double-blindness in the clinical application of acupuncture combined with traditional Chinese medicine. Secondly, pregnancy and live birth rates are clinical trials' most reliable efficacy indicators for infertility. These two indicators are closely related to patients and have tremendous clinical significance. However, the live birth rate requires long-term follow-up of all patients. Unfortunately, none of these articles have data on live birth rates. Thirdly, most of the studies included in this meta-analysis used inconsistent acupuncture points and herbal decoctions. In traditional Chinese medicine, combining different acupoints and herbs will lead to other effects, and factors such as the preparation of the herbs and the method of decoction will affect the therapeutic effect. Therefore, we did not select specific acupoints or traditional Chinese medicines, and we believe that the review's conclusions are general. Finally, there are irregularities in the evaluation criteria for symptom relief, and the results largely depend on the patient's subjective evaluation. Therefore, a larger, high-quality, multicenter RCT should be performed. The data included are published reports, excluding any grey literature (workshop proceedings, unpublished reports, presentations, and evidence from unconventional sources) and ongoing research. We only analyzed published studies, so unpublished studies with negative results may be missed. Therefore, the efficacy indicators may not reflect the actual situation. All included RCTs were conducted in China, which may lead to publication bias and affect the validity and reliability of this systematic review. Implications for research JAMA recommends that HSG (Hysterosalpingography) be used in diagnosing TOI to identify the site of obstruction, followed by surgical repair (e.g., hysteroscopy with tubal cannulation for proximal tubal obstruction, tubal re-anastomosis, or fimbrioplasty for distal obstruction) or IVF. Although surgical treatment can restore tubal patency in the short term and increase the odds of pregnancy in women with TOI, it also increases the risk of infection and lumen adhesions postoperatively [ 37 ] . In some Asian countries, acupuncture and CHM are commonly used in TOI as a complementary and alternative therapy. Although acupuncture and traditional Chinese medicine can increase the pregnancy rate and improve the degree of tubal blockage, there is a lack of high-level evidence-based medical research. Therefore, further studies on the efficacy and safety of acupuncture and CHM in treating TOI are encouraging and promising. However, doctors tend to choose acupoints and herbs based on the syndrome differentiation theory (a key concept in TCM), which leads to subjectivity in selecting acupoints and herbs. At the same time, the non-uniform diagnosis and treatment standards will also affect the objective evaluation of the curative effect. Therefore, in the future, it is necessary to urge standardized diagnosis and treatment, explore more appropriate treatment methods, and establish a standardized TOI treatment system in traditional Chinese medicine. Conclusion Based on the current clinical data, we can confirm that acupuncture combined with traditional Chinese medicine is an effective alternative therapy for the treatment of tubal obstructive infertility and has good results in improving pregnancy rate, tubal recanalization rate, and symptom relief. In particular, the occurrence of ectopic pregnancy is also relatively rare. However, an evaluation of the literature according to strict randomization, double-blind, and follow-up found that the quality of the evidence was low, and the evidence for the therapeutic effect of acupuncture combined with traditional Chinese medicine was insufficient. Therefore, future research may consider focusing on well-designed authoritative studies with rigorously conceived, randomized, and controlled trials to provide conclusive evidence and re-evaluate effects. Declarations Competing interests The authors declare that they have no conflict of interests. Authors' contributions Xia Han had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Wenrui Huang Acquisition, analysis, or interpretation of data: Wenrui Huang and Xia Han. Drafting of the manuscript: Wenrui Huang, Huimin Jie and TingTing Huang. Critical revision of the manuscript for important intellectual content: Yixin Li. Statistical analysis: Wenrui Huang and Xia Han. Obtained funding: none. Administrative, technical, or material support: Xia Han. Study supervision: Xia Han. All authors reviewed the manuscript. Funding not applicable Availability of data and materials The authors declare that all the meta-analysis data supporting the findings of this study are available within the article. References Farquhar, C. M., Bhattacharya, S., Repping, S., Mastenbroek, S., Kamath, M. S., & Marjoribanks, J., et al. (2019). Female subfertility. Nature Reviews Disease Primers, 5(1). Yilin Ke. (2014). The pregnancy assessment of tubal factor infertility Tubal Evaluation System(Master's thesis, Fudan University). Organization, W. H.. (1992). Recent advances in medically assisted conception: report of a who scientific group [meeting held in Geneva from 2 to 6 April 1990]. Who Scientific Group on Recent Advances in Medically Assisted Conception. Audu, B. M., Massa, A. A., Bukar, M., El-Nafaty, A. U., & Sa"Ad, S. T.. (2009). Prevalence of utero-tubal infertility. Journal of Obstetrics & Gynaecology, the Journal of the Institute of Obstetrics & Gynaecology, 29(4), 326–328. Nyboe Andersen, A., Goossens, V., Ferraretti, A. P., Bhattacharya, S., Felberbaum, R., De Mouzon, J., & Nygren, K. G. (2008). Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Human reproduction, 23(4), 756–771 Siyi Wu, Hui Gao, Yulan Liu, Youqin Hu, Panpan Li & Qingshuang Zhang. (2020). Research progress of traditional Chinese medicine in the treatment of tubal obstructive infertility. Hebei Traditional Chinese Medicine (12), 1890–1896. Moher, D.. (2010). Corrigendum to: preferred reporting items for systematic reviews and meta-analyses: the Prisma statement. International journal of surgery 2010;8:336–341. International Journal of Surgery, 8(8), 658-. Higgins, J. P., & Green, S.. (2009). Cochrane Handbook for Systematic Reviews of Interventions. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. Bing Kang, Hongyan Meng, Qingxin Yan, & Jiangong Ma. (2021). Clinical observation of warm acupuncture and moxibustion in the treatment of tubal obstruction infertility. Shanghai Journal of Acupuncture, 40(2), 6. Chao Xu, Guo Li, Jingjing Xiao, & Yongchao Fan. (2021). Efficacy observation of acupuncture combined with traditional Chinese medicine orally and externally in the treatment of tubal obstructive infertility. Practical Clinical Integrative Medicine, 21(7), 3. Dehong Yang, Xingxiu Zhan, & Xingwang Zhan. (2011). Hysteroscopic laparoscopy combined with traditional Chinese medicine quintuple therapy for the treatment of 46 cases of tubal infertility. Chinese and Foreign Women and Children's Health (9X), 2. Donghong Zhang, & Huizhen Feng. (2014). Clinical observation on the treatment of tubal obstructive infertility by oral administration of traditional Chinese medicine combined with warm acupuncture and moxibustion and tubal drenching solution. Contemporary Medicine, 20(30), 2. Fenzhu Wang. (2014). Traditional Chinese medicine combined with acupuncture in the treatment of 55 cases of tubal obstruction infertility. Modern Distance Education of Chinese Medicine in China (13), 2. Jumou Xiong. (2019). Analysis of clinical efficacy of acupuncture combined with traditional Chinese medicine on salpingitis obstructive infertility. World Latest Medical Information Digest (64), 2. Li Ding, Pingjun Wang, Shumei Zhu, Guiying Liu, & Cunli Cao. (2014). A clinical study of acupuncture combined with traditional Chinese medicine in the treatment of tubal obstructive infertility. Modern Journal of Integrative Medicine, 23(17), 3. Mingyu Wu, & Xiaojuan Deng. (2013). Clinical observation of 40 cases of tubal obstructive infertility treated with traditional Chinese medicine and acupuncture. Chinese Medicine Herald, 19(6), 2. Min Zhang, Jin Guo, Hanzhang Dong, Tonglong Liu, Jin Gong & Kaixiang Xing. (2012). Integrative Chinese and Western Medicine in the Treatment of 60 Cases of Tubal Obstructive Infertility. Sichuan Traditional Chinese Medicine (08), 84–86. Ning Han. (2012). Observation on the efficacy of integrated traditional Chinese and Western medicine in the treatment of tubal obstructive infertility. Chinese and Foreign Medicine, 31(7), 1. Pingshan Chen, & Jilin Kuang. (2010). Summary of 30 cases of tubal obstructive infertility treated by comprehensive therapy. Hunan Journal of Traditional Chinese Medicine (6), 2. Qunying Li. (2019). Clinical efficacy of oral administration of traditional Chinese medicine plus enema combined with acupuncture in the treatment of tubal obstructive infertility. Massage and Rehabilitation Medicine, 10(13), 3. Shenhua Yang, Jinfu Zheng, & Yunju Liang. (2021). Clinical observation of acupuncture on acupoints combined with oral traditional Chinese medicine in the treatment of infertility with proximal tubal obstruction. Electronic Journal of Practical Gynecology and Endocrinology, 8(3), 4. Yalei He, Yongyi Guo, & Fang Wu. (2018). Clinical effect of tubal intervention, acupuncture combined with traditional Chinese medicine compound in the treatment of blood stasis type tubal obstructive infertility. China Minkang Medicine, 30(14), 3. Yanjun Wang, Ma Lan, Jianhui Li, & Yijie. (2017). Clinical study of oral administration of traditional Chinese medicine plus enema combined with acupuncture in the treatment of 60 cases of tubal obstructive infertility. China Family Planning and Obstetrics, 9(2), 4. Yanling Pan, Wenhong Liu, Huili Wang, & Danqing Zhao. (2009). Observation on the curative effect of integrated traditional Chinese and Western medicine in the treatment of tubal obstructive infertility. Modern Journal of Integrated Chinese and Western Medicine, 18(2), 2. Yanmei Li. (2005). Clinical study of warm acupuncture combined with oral administration of traditional Chinese medicine in the treatment of tubal obstructive infertility. (Doctoral dissertation, Shandong University of Traditional Chinese Medicine). Zongwei Zhang. (2013). Clinical observation of combined acupuncture and medicine in the treatment of infertility patients with tubal obstruction after laparoscopic surgery. (Doctoral dissertation, Nanjing University of Traditional Chinese Medicine). Xia Han, Zhihua Peng & Sufang Jin. (2017). Effects of Huayu Tongyun Recipe on ICAM-1 expression and rheology in rats with salpingitis obstructive infertility. New Chinese Medicine (07), 13–16. doi: 10.13457/j.cnki.jncm.2017.07.004. Zhihua Peng, Xia Han, Lixia Yang. Juan Xu, Yufeng Xie & Jin Sufang. (2016). Acupuncture combined with traditional Chinese medicine on the expression of sICAM-1 protein in salpingitis obstructive infertility. New Chinese Medicine (08), 306–308. doi: 10.13457/j.cnki.jncm.2016.08.134. Wang, H. (2012). Effect of yishen tiaozhou method on β-endorphin in pof model rats. Journal of Clinical Acupuncture and Moxibustion. Bossut, D. F., Stromberg, M. W., & Malven, P. V.. (1986). Electroacupuncture-induced analgesia in sheep: measurement of cutaneous pain thresholds and plasma concentrations of prolactin and beta-endorphin immunoreactivity. American Journal of Veterinary Research, 47(3), 669. Xusheng Ban, Xiaofeng Shi. (1996). Acupuncture and dressing in the treatment of 116 cases of tubal obstructive infertility. Chinese Acupuncture, 16(3), 3. Yan Yin, & Yingchun Zhang. (2016). Two cases of successful pregnancy with unicornuate uterus with salpingitis treated with acupuncture and medicine. Journal of Hubei University of Traditional Chinese Medicine. Xiaohua Li, Weiwei Dong, Xiaoqi Zheng, & Huiqun Xu. (2016). The effect of combined acupuncture and medicine intervention on patients with ovulation disorder and unilateral fallopian tube obstruction. Chinese Journal of Basic Medicine of Traditional Chinese Medicine, 22(9), 4. Wu, Y., Chen, L. T., Qu, F., Sheikh, I. S., & Wu, Y. T.. (2014). Chinese herbal medicine for premature ovarian failure: a systematic review and meta-analysis. European Journal of Integrative Medicine, 6(3), 382–391. Zierau, O., Zheng, K., Papke, A., Dong, T., Tsim, K., & Vollmer, G.. (2014). Functions of danggui buxue tang, a chinese herbal decoction containing astragali radix and angelicae sinensis radix, in uterus and liver are both estrogen receptor-dependent and -independent. Evidence-Based Complementray and Alternative Medicine,2014,(2014-8-19), 2014, 438531. Ernst, Lee, & MS. (2008). A trial design that generates only "positive" results. Journal of Postgraduate Medicine, 54(3), 214–216. Carson, S. A., & Kallen, A. N. (2021). Diagnosis and management of infertility: a review. Jama, 326(1), 65–76. Table Table 1 is available in the Supplementary Files section Additional Declarations No competing interests reported. Supplementary Files Table1CharacteristicsoftheincludedRCTs..png Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-2059117","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":136695395,"identity":"cf0d5ac9-629e-4c30-a0a4-27ec06d5d3da","order_by":0,"name":"Wenrui Huang","email":"","orcid":"","institution":"The Six Clinical Medical College of Guangzhou University of Chinese Medicine","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Wenrui","middleName":"","lastName":"Huang","suffix":""},{"id":136695396,"identity":"c9b09d2f-faff-4bd1-95c6-fe7e27e51f63","order_by":1,"name":"Xia Han","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAzklEQVRIiWNgGAWjYBACfvnzHx9IVLDVs7E3H3xAlBbJGQzGBhZn+BL4eI4lGxClxeAGg5lEZZtcgpxEjpkEcVpuNyQb3Dhjlscm+QaopcYmmrDD7hw4+HBGRVoxmzTIlmNpuQ2EtPAdSGw2ljhzjLENpIWx4TBhLQwHktmk/7b9Z2yTPLvtBlFaBG6ksUlItrEltknwfKsgSotkzxlmA4kzbMZsPGnJBgnE+IWfvYcRFJVy8u2HL774UGNDhF9QQAJpykfBKBgFo2AU4AIARV9CM3bSZFwAAAAASUVORK5CYII=","orcid":"","institution":"Shenzhen Hospital of Guangzhou University of Chinese Medicine (FUTIAN)","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Xia","middleName":"","lastName":"Han","suffix":""},{"id":136695397,"identity":"26531ac6-44fd-4e3a-b80a-9f0d5c9cbf28","order_by":2,"name":"Yixin Li","email":"","orcid":"","institution":"The Six Clinical Medical College of Guangzhou University of Chinese Medicine","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Yixin","middleName":"","lastName":"Li","suffix":""},{"id":136695398,"identity":"7fbdb4ad-c0df-4cfe-a226-3a0d6ec536c4","order_by":3,"name":"Tingting Huang","email":"","orcid":"","institution":"The Six Clinical Medical College of Guangzhou University of Chinese Medicine","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Tingting","middleName":"","lastName":"Huang","suffix":""},{"id":136695400,"identity":"879311d0-011d-4984-a4cf-8098eed8d227","order_by":4,"name":"Huimin Jie","email":"","orcid":"","institution":"The Six Clinical Medical College of Guangzhou University of Chinese Medicine","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Huimin","middleName":"","lastName":"Jie","suffix":""}],"badges":[],"createdAt":"2022-09-13 05:29:12","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-2059117/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-2059117/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":26578675,"identity":"bd7034c5-9c97-46a0-bb7f-fcc35ebfbb59","added_by":"auto","created_at":"2022-09-16 20:43:02","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":241668,"visible":true,"origin":"","legend":"\u003cp\u003eLegend not included with this version.\u003c/p\u003e","description":"","filename":"Figure1.Flowchartillustratingtheprocessofstudyselection.png","url":"https://assets-eu.researchsquare.com/files/rs-2059117/v1/78ca7505d8c57a8402d2138d.png"},{"id":26579804,"identity":"83993644-d001-43f5-8fb0-cbbb8288964a","added_by":"auto","created_at":"2022-09-16 20:48:02","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":56003,"visible":true,"origin":"","legend":"\u003cp\u003eLegend not included with this version.\u003c/p\u003e","description":"","filename":"Figure2Riskofbiasgraph.png","url":"https://assets-eu.researchsquare.com/files/rs-2059117/v1/711f268c9321e51382bb4219.png"},{"id":26578680,"identity":"668621b1-082c-4efc-ae21-06593c7ab53c","added_by":"auto","created_at":"2022-09-16 20:43:02","extension":"png","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":251659,"visible":true,"origin":"","legend":"\u003cp\u003eLegend not included with this version.\u003c/p\u003e","description":"","filename":"Figure3Riskofbiassummary.png","url":"https://assets-eu.researchsquare.com/files/rs-2059117/v1/d90119ead2dcab6a8fabeb71.png"},{"id":26578677,"identity":"ad422a9b-eb7c-4132-a847-61b856b1065b","added_by":"auto","created_at":"2022-09-16 20:43:02","extension":"png","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":52041,"visible":true,"origin":"","legend":"\u003cp\u003eLegend not included with this version.\u003c/p\u003e","description":"","filename":"fig.4pregnancyrateFunnelplot.png","url":"https://assets-eu.researchsquare.com/files/rs-2059117/v1/b9018919f45972cc90ebce74.png"},{"id":26578678,"identity":"4621e954-b2d6-48ff-8db6-95884f34c58f","added_by":"auto","created_at":"2022-09-16 20:43:02","extension":"png","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":441455,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend.\u003c/p\u003e","description":"","filename":"fig.5Forestplot.png","url":"https://assets-eu.researchsquare.com/files/rs-2059117/v1/90d60ea46a61e242448e5f7d.png"},{"id":26614391,"identity":"8830c98e-205c-4492-8cb6-85b741d98f28","added_by":"auto","created_at":"2022-09-18 10:29:28","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1004188,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-2059117/v1/f62c90db-8b80-47bd-b2d3-6f76c935f36c.pdf"},{"id":26579803,"identity":"bf7c667e-4066-4166-955a-86d1afc8d28c","added_by":"auto","created_at":"2022-09-16 20:48:02","extension":"png","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":714022,"visible":true,"origin":"","legend":"","description":"","filename":"Table1CharacteristicsoftheincludedRCTs..png","url":"https://assets-eu.researchsquare.com/files/rs-2059117/v1/da43d9cd606443545c6fd111.png"}],"financialInterests":"No competing interests reported.","formattedTitle":"Acupuncture Combined with Chinese Herbal Medicine for Tubal Obstructive Infertility: A Systematic Review and Meta-Analysis","fulltext":[{"header":"Introduction","content":"\u003cp\u003eCommon causes of female infertility include ovulatory dysfunction (e.g., PCOS), damaged or blocked fallopian tubes, endometriosis, and uterine fibroids \u003csup\u003e[\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]\u003c/sup\u003e, among which tubal patency is abnormal due to tubal blockage, adhesions, etc. The resulting infertility is called Tubal Obstructive Infertility(TOI) \u003csup\u003e[\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e]\u003c/sup\u003e, accounting for 11\u0026ndash;67% of female infertility.\u003csup\u003e[\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e][\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e]\u003c/sup\u003e\u003c/p\u003e \u003cp\u003eAs the primary infertility factor, tubal infertility seriously affects women's reproductive health and quality of life. Western medicine mainly adopts surgical methods to treat TOI, such as hysteroscopy, laparoscopy, and other minimally invasive techniques to mechanically dredge the fallopian tubes, to achieve the effect of loosening adhesions. Although the minimally invasive technique has an apparent curative effect, minor trauma, and short treatment time, once the fresh wound of the fallopian tube mucosa is infected, it will easily lead to re-adhesion, obstruction, and the possibility of inflammatory lesions. Although Assisted Reproductive Technologies(ART) have primarily solved the problem of tubal infertility, the pregnancy rate has not improved clinically, from about 29\u0026ndash;35% \u003csup\u003e[\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e]\u003c/sup\u003e. There are also adverse reactions such as miscarriage, ectopic pregnancy, and ovarian hyperstimulation, which are unsuitable for promotion.\u003c/p\u003e \u003cp\u003eGiven the above phenomenon, there have been a large number of clinical research reports that Traditional Chinese Medicine has significant curative effects in the treatment of tubal obstructive infertility, such as eliminating chronic inflammation, reducing edema, restoring tubal function, and improving pregnancy rate, and has the advantages of less trauma, low cost, and high patient compliance\u003csup\u003e[\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]\u003c/sup\u003e. Although there are many reports on controlled clinical trials of acupuncture combined with Chinese herbal medicine (CHM) in the treatment of tubal obstructive infertility, there is no systematic review of these trials in China and abroad, and it is difficult to determine an appropriate evidence-based treatment plan. Therefore, we conducted this study to evaluate the potential therapeutic effect of acupuncture combined with CHM in treating tubal obstructive infertility.\u003c/p\u003e"},{"header":"Methods","content":"\u003cp\u003e This study was conducted by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement.\u003csup\u003e[\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e]\u003c/sup\u003e\u003c/p\u003e \u003cp\u003eDatabases including the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI), VIP information database, Wanfang Data Information Site, and Chinese Biomedical Database (CBM) were searched from inception to July 31, 2022. We also manually searched conference proceedings, reference lists of relevant articles, and reviewed articles to obtain additional relevant data. The following search terms were used for searching databases: (\"infertility, female\" or \"female infertility\" or \"subfertility\") and (\"fallopian tube diseases\" or \"tubal obstruction\" or \"fallopian tubal obstruction\") and (\"Chinese herbal drugs\" or \"Chinese herbal medicines\" or \"oriental herbal medicine\" or \"medicine, East Asian traditional\" or \"traditional Chinese medicine\" or \"medicine, Kampo\") and (\"acupuncture\" or \"moxibustion\" or \"point, acupuncture\" or \"acupoints\" or \"electroacupuncture\" or \"warming needle\" or \"auricular acupressure\" or \"auricular points\") and (\"randomized controlled trial\" or \"randomized\" or \"Placebo\" or \"RCT\" ).\u003c/p\u003e \u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003eStudy selection and data extraction\u003c/h2\u003e \u003cp\u003e In this review, only RCTs were eligible for inclusion, comparing the efficacy and safety of acupuncture and CHM versus fallopian tube hydrotubation for TOI.\u003c/p\u003e \u003cp\u003eA woman diagnosed with TOI was eligible for this research. (1) At least one year of regular sexual intercourse without contraception and male infertility;(2) The woman has not become pregnant, or a woman fails to conceive one year or more after a previous pregnancy; (3) infertility caused by oviduct obstruction can be identified with congested Oviduct under hysterosalpingogram (HSG), hysteroscopy, laparoscopy, or liquid flow under ultrasound hysterosalpingography.\u003c/p\u003e \u003cp\u003eThis study compares acupuncture combined with CHM and hydrotubation. In this review, Chinese medicine includes herbal decoctions, powder, and capsules. Acupuncture included body acupuncture and a warming needle. Interventions of the specific herbs and acupoints in the prescriptions should be provided. The control group interventions were Hydrotubation, which includes conventional hydrotubation, hysteroscopic hydrotubation, laparoscopic tubal correction with hydrotubation, and intervention therapy with hydrotubation and antibiotic drugs, with or without TCM treatment.\u003c/p\u003e \u003cp\u003eThe Primary outcome was the pregnancy rate. It is a positive urine or blood pregnancy test. Intrauterine pregnancy should be identified with intrauterine gestational sac Or fetal heartbeat by ultrasound. The Secondary outcome was tubal recanalization, and we defined the effectiveness of treatment as successful tubal recanalization or improvements detected by hysterosalpingography, hysteroscope, laparoscope, or ultrasound. The tertiary outcome was Relief of clinical symptoms and signs. The integration method was applied to determine the total effects in alleviating the signs and symptoms.\u003c/p\u003e \u003cp\u003eWe conducted the selection process through EndNote X7 software, a tool that allows multiple people to log in simultaneously. Thus, two review authors (HTT, XHM) independently screened studies by title and abstract to evaluate whether a study met the inclusion and exclusion criteria. We resolved disagreements by involving a third review author (LYX). We drew a PRISMA flow diagram to show the search results and the numbers of included and excluded trials. For all included trials, two review authors (HTT, XHM) independently extracted data using a data abstraction form and summarized trial characteristics in tables. From each included study, two review authors (HTT, XHM) derived baseline characteristics of TOI females, types of interventions (acupoints, drugs, doses), and outcomes. We intended to contact the study investigators for further data on methods and results if required. The criteria of Cochrane\u0026rsquo;s risk of bias assessment tool\u003csup\u003e[\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]\u003c/sup\u003e evaluated the bias risks of included articles. Two evaluators were designated to assess the reports in terms of the following items by giving the results of \u0026ldquo;high,\" \u0026ldquo;low,\" and \u0026ldquo;unclear\" independently: (1) Generation of random sequence; (2) Allocation concealment; (3) Blind method implementation to the researchers and subjects; (4) Blind method implementation to the outcome index evaluation; (5) Data integrity; (6) Selective report of study results; (7) Other bias sources.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec4\" class=\"Section2\"\u003e \u003ch2\u003eData analysis and synthesis\u003c/h2\u003e \u003cp\u003e Analyses were performed using Revman 5 statistical software provided by Cochrane collaboration. We used the relative risk (RR) for enumeration data. If the incidences were low, we used the odds ratio (OR) and estimated the corresponding 95% confidence interval (CI). The Chi-square test was used to measure heterogeneity. We used the fixed effects meta-analysis modeling if between-study heterogeneity was not observed. In the presence of between-study heterogeneity, we analyzed the quality of the methodology, the age of patients, the time of follow-up visits, and the sample size of the trial to find the factors affecting heterogeneity, excluded trials of statistically significant differences, and did sensitivity analyses. If no factors were identified, we used the random effects meta-analysis modeling.\u003c/p\u003e \u003c/div\u003e"},{"header":"Results","content":"\u003cp\u003eIn this review, 1580 relevant articles were retrieved. After importing all the studies into EndNote X7 software, 863 duplicate studies were excluded. By screening, titles, and abstracts of the remaining 33 records, 830 articles were excluded because of ineligibility, such as case reports, case series, traditional reviews, commentary articles, animal experiments, or not rigorously designed RCTs. Fifteen of the remaining 33 studies were excluded by examining the body texts. Among them, two articles had no relevant outcome; 13 studies didn't meet the inclusion of Intervention. Finally, 18 studies were selected for meta-analysis. (Fig.\u0026nbsp;1)\u003c/p\u003e \u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003eStudy characteristics\u003c/h2\u003e \u003cp\u003eThis review included 18 RCTs.\u003csup\u003e[\u003cspan additionalcitationids=\"CR10 CR11 CR12 CR13 CR14 CR15 CR16 CR17 CR18 CR19 CR20 CR21 CR22 CR23 CR24 CR25\" citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]\u003c/sup\u003eAll of them were single-center studies, including women, 837 in trial groups and 786 in control groups. All the available data compared acupuncture and CHM versus hydrotubation for TOI(table-1).\u003c/p\u003e \u003cp\u003eAll the incorporated documents were randomly allocated, and all the trials were considered a low risk of selection bias. All the included trials did not mention allocation concealment and were rated as unclear risk of bias. Ten studies provided information on blind methods and were assessed as having a \u0026ldquo;high\u0026rdquo; risk of bias. \u003csup\u003e[\u003cspan additionalcitationids=\"CR10\" citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e, \u003cspan additionalcitationids=\"CR14 CR15\" citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]\u003c/sup\u003e. During treatment and follow-up, 18 trials did not report exclusion or loss and were rated low risk. The protocols of included studies have not been published, and all experiments have not been registered, which we judged as an unclear risk of bias. We found no potential within-study bias in the 18 documents and rated them low risk (Fig.\u0026nbsp;2 and Fig.\u0026nbsp;3).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec7\" class=\"Section2\"\u003e \u003ch2\u003eClinical outcomes\u003c/h2\u003e \u003cp\u003eEighteen trials\u003csup\u003e[\u003cspan additionalcitationids=\"CR10 CR11 CR12 CR13 CR14 CR15 CR16 CR17 CR18 CR19 CR20 CR21 CR22 CR23 CR24 CR25\" citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]\u003c/sup\u003e reported pregnancy rates which were categorical data. Between-study heterogeneity was tested (X\u0026sup2; = 10.80, P\u0026thinsp;=\u0026thinsp;0.87). No factors that cause heterogeneity were found through analysis. We then used fixed effects modeling for meta-analysis. The results indicated that compared with hydrotubation (with or without TCM treatment), Acupuncture combined with CHM was associated with higher pregnancy rates [RR 1.74, 95% CI (1.54, 1.95), P༜0.00001] (Fig.\u0026nbsp;4). The asymmetry funnel plot(Fig.\u0026nbsp;5) showed publication bias.\u003c/p\u003e \u003cp\u003eSixteen trials\u003csup\u003e[\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e, \u003cspan additionalcitationids=\"CR13\" citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e, \u003cspan additionalcitationids=\"CR17 CR18 CR19 CR20 CR21 CR22 CR23 CR24 CR25\" citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]\u003c/sup\u003e reported the conditions of tubal recanalization. Heterogeneity was observed (x\u0026sup2; = 21.76, P\u0026thinsp;=\u0026thinsp;0.11). No factors that cause heterogeneity were found through analysis. We then used fixed effects modeling for meta-analysis. The results indicated that Acupuncture combined with CHM is more effective than hydrotubation. [RR 1.37, 95% CI (1.20, 1.57), P༜0.00001] (Fig.\u0026nbsp;4).\u003c/p\u003e \u003cp\u003eSix trials\u003csup\u003e[\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e, \u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e, \u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]\u003c/sup\u003e reported the relief of signs and symptoms, which were categorical data. No significant heterogeneity was observed (x\u0026sup2; = 5.54, P\u0026thinsp;=\u0026thinsp;0.35), we then used fixed effects modeling for meta-analysis. The results suggested that Acupuncture combined with CHM can better relieve the signs and symptoms than hydrotubation. [OR 3.44, 95% CI (2.22, 5.33), P༜0.00001] (Fig.\u0026nbsp;4).\u003c/p\u003e \u003cp\u003eAmong the 18 trials mentioned above, three reported cases of ectopic pregnancy \u003csup\u003e[\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e, \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e, \u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e]\u003c/sup\u003e, which were categorical data. No significant heterogeneity was observed (x\u0026sup2; = 0.04, P\u0026thinsp;=\u0026thinsp;0.98); we therefore used fixed effects modeling for meta-analysis. The results showed that hydrotubation was associated with a higher incidence of ectopic pregnancy compared with Acupuncture combined with CHM [OR 0.61, 95% CI (0.19, 1.92), P\u0026thinsp;=\u0026thinsp;0.40] (Fig.\u0026nbsp;4).\u003c/p\u003e \u003c/div\u003e"},{"header":"Discussion","content":"\u003cp\u003eIn this study, we searched all the data about acupuncture combined with Chinese medicine for infertility caused by tubal obstructive and retrieved 33 relevant studies. Eighteen randomized controlled trials were included, involving 1623 patients. The results indicated that:(1) Compared with hydrotubation, acupuncture combined with CHM for tubal obstructive infertility was associated with a higher pregnancy rate, better tubal recanalization, and better relief of signs and symptoms. (2) The incidence of ectopic pregnancy was lower using acupuncture combined with CHM than with hydrotubation for infertility caused by tubal obstruction. This study suggests that there is a prospect for acupuncture combined with CHM in the treatment of infertility caused by tubal obstruction. Slight abdominal pain was observed during and after the operation, and recovery from the pain was achieved in a week without special treatment. No noticeable side effects were detected after drinking decoction, applying Chinese medicine externally, or by enema. Slight allergies in local areas were alleviated without any treatment. No abnormal changes were seen on lab test indexes (blood and urine routine examination) or type-B ultrasonic probe with pelvic cavity before and after the administration.\u003c/p\u003e \u003cdiv id=\"Sec9\" class=\"Section2\"\u003e \u003ch2\u003eMechanisms of acupuncture and CHM\u003c/h2\u003e \u003cp\u003eAlthough the Acupuncture points and CHM selected in these 18 articles are not the same, we can still find more commonly used herbs and acupoints in them. The following twelve acupoints have been used in more than five (including five) studies, including Zigong(EX-CA1), Zhongji(RN3), Qihai(RN6), Sanyinjiao(SP6), Guanyuan(RN4), Shenshu(BL23), Zusanli(ST36), Xuehai(SP10), Taichong(LR3), Ganshu(BL18), Ciliao(BL32), Mingmen(DU4). The following eight herbs had been most frequently used in more than five (including five) studies, including Danggui(Angelica Sinensis), Chishao(Radix Paeoniae Rubra), Baizhu(Atractylodes macrocephala), Dangshen(Codonopsis pilosula), Gancao(liquorice), Danshen(Salvia miltiorrhiza), Lulutong(Fructus liquidambaris), Baijiangcao(Herbal patriniae).\u003c/p\u003e \u003cp\u003eThe evidence of Acupuncture and CHM for TOI includes the following aspects: (1)Improving the hemodynamics of the ovary and uterus. A study showed that Chinese herbal medicine treating salpingitis obstructive infertility could effectively improve the hemodynamic rheological indicators of the uterus and ovary. In this study, the hemorheological indexes of the rats in the tubal obstructive infertility model in the experimental group were significantly lower than those in the western medicine group treated with cefuroxime and metronidazole. Another study showed that acupuncture combined with traditional Chinese medicine in treating salpingitis obstructive infertility could inhibit the expression of sICAM-1 protein, effectively improve hemorheological indicators, and promote the absorption and dissipation of inflammation. \u003csup\u003e[\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e][\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]\u003c/sup\u003e(2)Regulating immunity. A study confirmed that acupuncture could effectively increase the levels of β-endorphins in rats' peripheral blood and hypothalamus\u003csup\u003e[\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e]\u003c/sup\u003e. In regulating the female gonadal axis, β-endorphin, an endogenous opioid peptide, is a universal messenger of the nervous, endocrine, and immune systems and plays a crucial role in neuromodulation and maintaining the stability of the body's internal environment\u003csup\u003e[\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e]\u003c/sup\u003e. Domestic studies have also shown that acupuncture can regulate the endocrine system, stimulate ovarian function, and acupuncture can promote the absorption of inflammation. It has incomparable advantages for dredging the fallopian tubes, promoting the combination of sperm and egg, and improving the pregnancy rate\u003csup\u003e[\u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e]\u003c/sup\u003e. (3)Regulates the hypothalamic-pituitary-ovarian axis. It has been reported at home and abroad that traditional Chinese medicine treatment can effectively improve women's ovarian function and increase the natural conception rate\u003csup\u003e[\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e] [\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e]\u003c/sup\u003e. A meta-analysis showed that treatment with CHM significantly reduced FSH levels in women\u003csup\u003e[\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e]\u003c/sup\u003e, and another study showed that Danggui Buxue decoction had estradiol activity in vitro\u003csup\u003e[\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e]\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eThe limitations of the included studies in this meta-analysis are as follows: Firstly, the methodological quality was low due to the lack of description of blinding in most of the included studies. Blinding is necessary to prevent study results from being influenced by placebo effects or observer bias\u003csup\u003e[\u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e36\u003c/span\u003e]\u003c/sup\u003e. However, in the related research on acupuncture, it is difficult to apply the blind method to the patient because acupuncture needs to be implemented on the patient. In addition, traditional Chinese medicine formulations are mainly decoctions, which can be better differentiated from clinical drug capsules or placebos. In conclusion, it is challenging to achieve double-blindness in the clinical application of acupuncture combined with traditional Chinese medicine. Secondly, pregnancy and live birth rates are clinical trials' most reliable efficacy indicators for infertility. These two indicators are closely related to patients and have tremendous clinical significance. However, the live birth rate requires long-term follow-up of all patients. Unfortunately, none of these articles have data on live birth rates. Thirdly, most of the studies included in this meta-analysis used inconsistent acupuncture points and herbal decoctions. In traditional Chinese medicine, combining different acupoints and herbs will lead to other effects, and factors such as the preparation of the herbs and the method of decoction will affect the therapeutic effect. Therefore, we did not select specific acupoints or traditional Chinese medicines, and we believe that the review's conclusions are general. Finally, there are irregularities in the evaluation criteria for symptom relief, and the results largely depend on the patient's subjective evaluation. Therefore, a larger, high-quality, multicenter RCT should be performed.\u003c/p\u003e \u003cp\u003eThe data included are published reports, excluding any grey literature (workshop proceedings, unpublished reports, presentations, and evidence from unconventional sources) and ongoing research. We only analyzed published studies, so unpublished studies with negative results may be missed. Therefore, the efficacy indicators may not reflect the actual situation. All included RCTs were conducted in China, which may lead to publication bias and affect the validity and reliability of this systematic review.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec10\" class=\"Section2\"\u003e \u003ch2\u003eImplications for research\u003c/h2\u003e \u003cp\u003eJAMA recommends that HSG (Hysterosalpingography) be used in diagnosing TOI to identify the site of obstruction, followed by surgical repair (e.g., hysteroscopy with tubal cannulation for proximal tubal obstruction, tubal re-anastomosis, or fimbrioplasty for distal obstruction) or IVF. Although surgical treatment can restore tubal patency in the short term and increase the odds of pregnancy in women with TOI, it also increases the risk of infection and lumen adhesions postoperatively\u003csup\u003e[\u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e37\u003c/span\u003e]\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eIn some Asian countries, acupuncture and CHM are commonly used in TOI as a complementary and alternative therapy. Although acupuncture and traditional Chinese medicine can increase the pregnancy rate and improve the degree of tubal blockage, there is a lack of high-level evidence-based medical research. Therefore, further studies on the efficacy and safety of acupuncture and CHM in treating TOI are encouraging and promising. However, doctors tend to choose acupoints and herbs based on the syndrome differentiation theory (a key concept in TCM), which leads to subjectivity in selecting acupoints and herbs. At the same time, the non-uniform diagnosis and treatment standards will also affect the objective evaluation of the curative effect. Therefore, in the future, it is necessary to urge standardized diagnosis and treatment, explore more appropriate treatment methods, and establish a standardized TOI treatment system in traditional Chinese medicine.\u003c/p\u003e \u003c/div\u003e"},{"header":"Conclusion","content":"\u003cp\u003eBased on the current clinical data, we can confirm that acupuncture combined with traditional Chinese medicine is an effective alternative therapy for the treatment of tubal obstructive infertility and has good results in improving pregnancy rate, tubal recanalization rate, and symptom relief. In particular, the occurrence of ectopic pregnancy is also relatively rare. However, an evaluation of the literature according to strict randomization, double-blind, and follow-up found that the quality of the evidence was low, and the evidence for the therapeutic effect of acupuncture combined with traditional Chinese medicine was insufficient. Therefore, future research may consider focusing on well-designed authoritative studies with rigorously conceived, randomized, and controlled trials to provide conclusive evidence and re-evaluate effects.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cem\u003eCompeting interests\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that they have no conflict of interests.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eAuthors' contributions\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eXia Han had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.\u003c/li\u003e\n\u003cli\u003eStudy concept and design: Wenrui Huang\u003c/li\u003e\n\u003cli\u003eAcquisition, analysis, or interpretation of data: Wenrui Huang and Xia Han.\u003c/li\u003e\n\u003cli\u003eDrafting of the manuscript: Wenrui Huang, Huimin Jie and TingTing Huang.\u003c/li\u003e\n\u003cli\u003eCritical revision of the manuscript for important intellectual content: Yixin Li.\u003c/li\u003e\n\u003cli\u003eStatistical analysis: Wenrui Huang and Xia Han.\u003c/li\u003e\n\u003cli\u003eObtained funding: none.\u003c/li\u003e\n\u003cli\u003eAdministrative, technical, or material support: Xia Han.\u003c/li\u003e\n\u003cli\u003eStudy supervision: Xia Han.\u003c/li\u003e\n\u003cli\u003eAll authors reviewed the manuscript.\u0026nbsp;\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eFunding\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003enot applicable\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eAvailability of data and materials\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that all the meta-analysis data supporting the findings of this study are available within the article.\u0026nbsp;\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n \u003cli\u003eFarquhar, C. M., Bhattacharya, S., Repping, S., Mastenbroek, S., Kamath, M. S., \u0026amp; Marjoribanks, J., et al. (2019). Female subfertility. Nature Reviews Disease Primers, 5(1).\u003c/li\u003e\n \u003cli\u003eYilin Ke. (2014). The pregnancy assessment of tubal factor infertility Tubal Evaluation System(Master\u0026apos;s thesis, Fudan University).\u003c/li\u003e\n \u003cli\u003eOrganization, W. H.. (1992). Recent advances in medically assisted conception: report of a who scientific group [meeting held in Geneva from 2 to 6 April 1990]. Who Scientific Group on Recent Advances in Medically Assisted Conception.\u003c/li\u003e\n \u003cli\u003eAudu, B. M., Massa, A. A., Bukar, M., El-Nafaty, A. U., \u0026amp; Sa\u0026quot;Ad, S. T.. (2009). Prevalence of utero-tubal infertility. Journal of Obstetrics \u0026amp; Gynaecology, the Journal of the Institute of Obstetrics \u0026amp; Gynaecology, 29(4), 326\u0026ndash;328.\u003c/li\u003e\n \u003cli\u003eNyboe Andersen, A., Goossens, V., Ferraretti, A. P., Bhattacharya, S., Felberbaum, R., De Mouzon, J., \u0026amp; Nygren, K. G. (2008). Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Human reproduction, 23(4), 756\u0026ndash;771\u003c/li\u003e\n \u003cli\u003eSiyi Wu, Hui Gao, Yulan Liu, Youqin Hu, Panpan Li \u0026amp; Qingshuang Zhang. (2020). Research progress of traditional Chinese medicine in the treatment of tubal obstructive infertility. Hebei Traditional Chinese Medicine (12), 1890\u0026ndash;1896.\u003c/li\u003e\n \u003cli\u003eMoher, D.. (2010). Corrigendum to: preferred reporting items for systematic reviews and meta-analyses: the Prisma statement. International journal of surgery 2010;8:336\u0026ndash;341. International Journal of Surgery, 8(8), 658-.\u003c/li\u003e\n \u003cli\u003eHiggins, J. P., \u0026amp; Green, S.. (2009). Cochrane Handbook for Systematic Reviews of Interventions. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol.\u003c/li\u003e\n \u003cli\u003eBing Kang, Hongyan Meng, Qingxin Yan, \u0026amp; Jiangong Ma. (2021). Clinical observation of warm acupuncture and moxibustion in the treatment of tubal obstruction infertility. Shanghai Journal of Acupuncture, 40(2), 6.\u003c/li\u003e\n \u003cli\u003eChao Xu, Guo Li, Jingjing Xiao, \u0026amp; Yongchao Fan. (2021). Efficacy observation of acupuncture combined with traditional Chinese medicine orally and externally in the treatment of tubal obstructive infertility. Practical Clinical Integrative Medicine, 21(7), 3.\u003c/li\u003e\n \u003cli\u003eDehong Yang, Xingxiu Zhan, \u0026amp; Xingwang Zhan. (2011). Hysteroscopic laparoscopy combined with traditional Chinese medicine quintuple therapy for the treatment of 46 cases of tubal infertility. Chinese and Foreign Women and Children\u0026apos;s Health (9X), 2.\u003c/li\u003e\n \u003cli\u003eDonghong Zhang, \u0026amp; Huizhen Feng. (2014). Clinical observation on the treatment of tubal obstructive infertility by oral administration of traditional Chinese medicine combined with warm acupuncture and moxibustion and tubal drenching solution. Contemporary Medicine, 20(30), 2.\u003c/li\u003e\n \u003cli\u003eFenzhu Wang. (2014). Traditional Chinese medicine combined with acupuncture in the treatment of 55 cases of tubal obstruction infertility. Modern Distance Education of Chinese Medicine in China (13), 2.\u003c/li\u003e\n \u003cli\u003eJumou Xiong. (2019). Analysis of clinical efficacy of acupuncture combined with traditional Chinese medicine on salpingitis obstructive infertility. World Latest Medical Information Digest (64), 2.\u003c/li\u003e\n \u003cli\u003eLi Ding, Pingjun Wang, Shumei Zhu, Guiying Liu, \u0026amp; Cunli Cao. (2014). A clinical study of acupuncture combined with traditional Chinese medicine in the treatment of tubal obstructive infertility. Modern Journal of Integrative Medicine, 23(17), 3.\u003c/li\u003e\n \u003cli\u003eMingyu Wu, \u0026amp; Xiaojuan Deng. (2013). Clinical observation of 40 cases of tubal obstructive infertility treated with traditional Chinese medicine and acupuncture. Chinese Medicine Herald, 19(6), 2.\u003c/li\u003e\n \u003cli\u003eMin Zhang, Jin Guo, Hanzhang Dong, Tonglong Liu, Jin Gong \u0026amp; Kaixiang Xing. (2012). Integrative Chinese and Western Medicine in the Treatment of 60 Cases of Tubal Obstructive Infertility. Sichuan Traditional Chinese Medicine (08), 84\u0026ndash;86.\u003c/li\u003e\n \u003cli\u003eNing Han. (2012). Observation on the efficacy of integrated traditional Chinese and Western medicine in the treatment of tubal obstructive infertility. Chinese and Foreign Medicine, 31(7), 1.\u003c/li\u003e\n \u003cli\u003ePingshan Chen, \u0026amp; Jilin Kuang. (2010). Summary of 30 cases of tubal obstructive infertility treated by comprehensive therapy. Hunan Journal of Traditional Chinese Medicine (6), 2.\u003c/li\u003e\n \u003cli\u003eQunying Li. (2019). Clinical efficacy of oral administration of traditional Chinese medicine plus enema combined with acupuncture in the treatment of tubal obstructive infertility. Massage and Rehabilitation Medicine, 10(13), 3.\u003c/li\u003e\n \u003cli\u003eShenhua Yang, Jinfu Zheng, \u0026amp; Yunju Liang. (2021). Clinical observation of acupuncture on acupoints combined with oral traditional Chinese medicine in the treatment of infertility with proximal tubal obstruction. Electronic Journal of Practical Gynecology and Endocrinology, 8(3), 4.\u003c/li\u003e\n \u003cli\u003eYalei He, Yongyi Guo, \u0026amp; Fang Wu. (2018). Clinical effect of tubal intervention, acupuncture combined with traditional Chinese medicine compound in the treatment of blood stasis type tubal obstructive infertility. China Minkang Medicine, 30(14), 3.\u003c/li\u003e\n \u003cli\u003eYanjun Wang, Ma Lan, Jianhui Li, \u0026amp; Yijie. (2017). Clinical study of oral administration of traditional Chinese medicine plus enema combined with acupuncture in the treatment of 60 cases of tubal obstructive infertility. China Family Planning and Obstetrics, 9(2), 4.\u003c/li\u003e\n \u003cli\u003eYanling Pan, Wenhong Liu, Huili Wang, \u0026amp; Danqing Zhao. (2009). Observation on the curative effect of integrated traditional Chinese and Western medicine in the treatment of tubal obstructive infertility. Modern Journal of Integrated Chinese and Western Medicine, 18(2), 2.\u003c/li\u003e\n \u003cli\u003eYanmei Li. (2005). Clinical study of warm acupuncture combined with oral administration of traditional Chinese medicine in the treatment of tubal obstructive infertility. (Doctoral dissertation, Shandong University of Traditional Chinese Medicine).\u003c/li\u003e\n \u003cli\u003eZongwei Zhang. (2013). Clinical observation of combined acupuncture and medicine in the treatment of infertility patients with tubal obstruction after laparoscopic surgery. (Doctoral dissertation, Nanjing University of Traditional Chinese Medicine).\u003c/li\u003e\n \u003cli\u003eXia Han, Zhihua Peng \u0026amp; Sufang Jin. (2017). Effects of Huayu Tongyun Recipe on ICAM-1 expression and rheology in rats with salpingitis obstructive infertility. New Chinese Medicine (07), 13\u0026ndash;16. doi: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.13457/j.cnki.jncm.2017.07.004.\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\n \u003cli\u003eZhihua Peng, Xia Han, Lixia Yang. Juan Xu, Yufeng Xie \u0026amp; Jin Sufang. (2016). Acupuncture combined with traditional Chinese medicine on the expression of sICAM-1 protein in salpingitis obstructive infertility. New Chinese Medicine (08), 306\u0026ndash;308. doi: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.13457/j.cnki.jncm.2016.08.134.\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\n \u003cli\u003eWang, H. (2012). Effect of yishen tiaozhou method on \u0026beta;-endorphin in pof model rats. Journal of Clinical Acupuncture and Moxibustion.\u003c/li\u003e\n \u003cli\u003eBossut, D. F., Stromberg, M. W., \u0026amp; Malven, P. V.. (1986). Electroacupuncture-induced analgesia in sheep: measurement of cutaneous pain thresholds and plasma concentrations of prolactin and beta-endorphin immunoreactivity. American Journal of Veterinary Research, 47(3), 669.\u003c/li\u003e\n \u003cli\u003eXusheng Ban, Xiaofeng Shi. (1996). Acupuncture and dressing in the treatment of 116 cases of tubal obstructive infertility. Chinese Acupuncture, 16(3), 3.\u003c/li\u003e\n \u003cli\u003eYan Yin, \u0026amp; Yingchun Zhang. (2016). Two cases of successful pregnancy with unicornuate uterus with salpingitis treated with acupuncture and medicine. Journal of Hubei University of Traditional Chinese Medicine.\u003c/li\u003e\n \u003cli\u003eXiaohua Li, Weiwei Dong, Xiaoqi Zheng, \u0026amp; Huiqun Xu. (2016). The effect of combined acupuncture and medicine intervention on patients with ovulation disorder and unilateral fallopian tube obstruction. Chinese Journal of Basic Medicine of Traditional Chinese Medicine, 22(9), 4.\u003c/li\u003e\n \u003cli\u003eWu, Y., Chen, L. T., Qu, F., Sheikh, I. S., \u0026amp; Wu, Y. T.. (2014). Chinese herbal medicine for premature ovarian failure: a systematic review and meta-analysis. European Journal of Integrative Medicine, 6(3), 382\u0026ndash;391.\u003c/li\u003e\n \u003cli\u003eZierau, O., Zheng, K., Papke, A., Dong, T., Tsim, K., \u0026amp; Vollmer, G.. (2014). Functions of danggui buxue tang, a chinese herbal decoction containing astragali radix and angelicae sinensis radix, in uterus and liver are both estrogen receptor-dependent and -independent. Evidence-Based Complementray and Alternative Medicine,2014,(2014-8-19), 2014, 438531.\u003c/li\u003e\n \u003cli\u003eErnst, Lee, \u0026amp; MS. (2008). A trial design that generates only \u0026quot;positive\u0026quot; results. Journal of Postgraduate Medicine, 54(3), 214\u0026ndash;216.\u003c/li\u003e\n \u003cli\u003eCarson, S. A., \u0026amp; Kallen, A. N. (2021). Diagnosis and management of infertility: a review. Jama, 326(1), 65\u0026ndash;76.\u003c/li\u003e\n\u003c/ol\u003e"},{"header":"Table","content":"\u003cp\u003eTable 1 is available in the Supplementary Files section\u003c/p\u003e\n"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Acupuncture, Chinese herbal medicines, Tubal infertility, Meta-analysis, systematic review","lastPublishedDoi":"10.21203/rs.3.rs-2059117/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-2059117/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground:\u003c/strong\u003e Tubal obstruction is the leading cause of infertility. Acupuncture and Chinese herbal medicine (CHM) are widely used in treating tubal obstruction infertility (TOI), and clinical research is increasing. However, there is still controversy about its efficacy and safety. This systematic review aimed to assess the efficacy and safety of acupuncture and CHM in treating TOI.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods:\u003c/strong\u003e We searched eight databases to collect randomized controlled trials comparing Hydrotubation with Acupuncture combined with CHM from inception to July 31, 2022. A total of 1580 papers were collected, and the methodological quality of the included trials was assessed in line with the criteria of the Cochrane risk of the bias assessment tool. In the end, only 18 randomized clinical trials met the requirements and were included.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults:\u003c/strong\u003e Meta-analysis showed that acupuncture and CHM was associated with a higher pregnancy rate [RR 1.74, 95% CI (1.54, 1.95), P \u0026lt; 0.00001] and a lower ectopic pregnancy rate [OR 0.61, 95 % CI (0.19, 1.92), P<0.0001]. The success rate of tubal recanalization was significantly improved with acupuncture combined with CHM treatment[RR 1.37, 95 % CI (1.20, 1.57), P<0.0001], and signs and symptoms were better relieved [OR 3.44, 95 % CI (2.22, 5.33), P<0.00001].\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusions: \u003c/strong\u003eThis meta-analysis suggests that acupuncture and CHM can be used as complementary therapies to treat tubal obstructive infertility with better outcomes than Hydrotubation.\u003c/p\u003e","manuscriptTitle":"Acupuncture Combined with Chinese Herbal Medicine for Tubal Obstructive Infertility: A Systematic Review and Meta-Analysis","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2022-09-16 20:43:00","doi":"10.21203/rs.3.rs-2059117/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"4fd38006-f5b6-4522-a4c2-a969f352cc6f","owner":[],"postedDate":"September 16th, 2022","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2022-09-18T10:29:18+00:00","versionOfRecord":[],"versionCreatedAt":"2022-09-16 20:43:00","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-2059117","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-2059117","identity":"rs-2059117","version":["v1"]},"buildId":"cBFmMYwuxLRRLfASyISRj","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

infertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-29T02:00:03.542394+00:00
License: CC-BY-4.0